EPs 7630
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EPs 7630, covering 2017-01-12 to 2024-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option [Phase 2, Phase 3]